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Secreted  cytokines  of the  TGF  family  are  found  in  all multicellular  organisms  and  implicated  in  reg-
ulating  fundamental  cell  behaviors  such  as  proliferation,  differentiation,  migration  and  survival.  Signal
transduction  involves  complexes  of  speciﬁc  type I and II receptor  kinases  that  induce  the  nuclear  translo-
cation  of  Smad  transcription  factors  to regulate  target  genes.  Ligands  of  the BMP  and  Nodal  subgroups
act  at  a distance  to specify  distinct  cell  fates  in a concentration-dependent  manner.  These  signaling  gra-
dients  are shaped  by  multiple  factors,  including  proteases  of  the proprotein  convertase  (PC)  family  that
hydrolyze  one  or several  peptide  bonds  between  an  N-terminal  prodomain  and  the  C-terminal  domainonvertases
PP precursor
atency
orphogen gradients
odal signaling
roprotein processing
that  forms  the  mature  ligand.  This  review  summarizes  information  on  the  proteolytic  processing  of  TGF
and  related  precursors,  and  its  spatiotemporal  regulation  by  PCs  during  development  and  various  dis-
eases, including  cancer.  Available  evidence  suggests  that  the  unmasking  of receptor  binding  epitopes  of
TGF  is only  one  (and  in some  cases  a non-essential)  function  of  precursor  processing.  Future studies
should  consider  the  impact  of  proteolytic  maturation  on  protein  localization,  trafﬁcking  and  turnover  in
cells  and  in the  extracellular  space.rotein sorting and trafﬁcking ©  2014  The  Author.  Published  by Elsevier  Ltd.  All rights  reserved.
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c. Introduction
.1. Mechanisms to control the bioavailability of TGF  ˇ ligands
More than 30 members of the TGF family comprising TGF
soforms, Activins, Nodal, BMP, GDF, and AMH  subgroups bind
ype I and II serine/threonine receptor kinases and, in some cases,
peciﬁc co-receptors at the plasma membrane to induce the phos-
horylation of Smad transcription factors and other signaling
olecules in the cytoplasm. A distant subgroup comprising GDNF
nd three cousins signal through the tyrosine kinase RET. Sev-
ral recent reviews describe TGF signal transduction pathways
nd their prominent roles in stem cells and development, cancer
nd other diseases, and current strategies for therapeutic target-
ng [1–4]. Much information is also available on the regulation
f TGF signaling at the level of transcription, ubiquitination
nd miRNA-mediated silencing of receptors, interactions with
o-receptors, endocytosis, Smad-interacting factors, and modi-
cation of Smad-target sites in DNA by chromatin-modifying
nzymes [1,2]. Of particular interest is the hyperactivation of
GF protein production as it is common in many solid can-
ers and contributes to tumor progression [5]. The bioavailability
f Nodal and BMPs also shapes morphogen signaling gradients
o pattern whole embryos and tissues during normal develop-
ent, together with feedback regulators that buffer ﬂuctuations
n expression levels and control signal duration and spreading
1,6,7]. In addition, reversible sequestration by inhibitory pro-
ein complexes is employed to redistribute and release active
igands within their expression domains [reviewed in 8–10].
enetic and epigenetic perturbations altering the expression lev-
ls of secreted BMP  antagonists such as Noggin, Gremlin-1 and
and5 (Coco/Cerl2) also contribute to the re-wiring of onco-
enic signaling in human cancers [reviewed in 1,11–14]. By
omparison, little is known about how TGF and related lig-
nds are released from seemingly inactive precursors, and no
revious review has been dedicated to this topic. This review
ill therefore ﬁrst describe molecular mechanisms that govern
he release of active TGF and related ligands after precursor
leavage, with a focus on the general and specialized functions
f individual prodomains in conferring latency (Table 1). I will
hen survey new roles of intracellular and secreted PCs that
ave been linked to TGF signaling in diverse contexts, fol-
owed by reﬂections on how they regulate proteolytic cleavage
nd to what end, and what aspects of this process merit further
nvestigation.
able 1
rodomains found in complexes with TGF-related mature ligands after precursor
leavage.
Inhibitory References
Activin A No [166,180]
BMP2,4,7 No [28,44]
BMP9 No [181]
BMP10 Yes [29]
GDF2 (Dorsalin) n.d. [67]
GDF5 No [28]
GDF8 (Myostatin) Yes [45,46]
GDF15 (MIC-1) n.d. [38]
GDF11 Yes [50]1.2. Precursor cleavage is not sufﬁcient to activate TGFˇ
TGF ligands mature from precursor dimers as proteolytic
fragments containing 7–9 conserved cysteines that stabilize a char-
acteristic cystine knot structure through 1 interchain and 3–4
intrachain disulphide bonds [15]. The N-terminal prodomain that is
cleaved off usually remains bound in an inactive small latent com-
plex (SLC) as a latency associated peptide (LAP). A crystal structure
of latent TGF (L-TGF) revealed that a homodimer of LAP is held
together like two arms at the neck by two  interchain disulphide
bonds. The forearms consisting of an N-terminal 1-helix and a
so-called latency lasso are buckled into a straightjacket around
mature ligand to mask receptor-binding epitopes [16] (Fig. 1A).
Dissociation from LAP is arguably the most critical step to regulate
TGF signal activation [3]. Possible mechanisms include dissoca-
tion at acidic pH or proteolysis of LAP by matrix metalloproteinases
[17]. Alternatively, the SLC is disrupted by tensile forces mediated
by speciﬁc integrins such as v6 or v8 that interact with an
RGD motif in LAP [16,18,19]. Knock-in mice with a substitution
of RGD by RGE phenocopy Tgfb1−/− mice, indicating that integrin-
mediated activation predominates in vivo [20]. Integrin-mediated
activation by tensile forces is regulated by L-TGF-binding pro-
teins (LTBP) in the extracellular matrix [21]. LTBP-1, -2 or -4 form
a disulphide bond with Cys33 at position 4 of the 1-helix of
LAP to facilitate the secretion and matrix deposition of TGF in
a large latent complex (LLC). Mutation of Cys33 in mice attenu-
ates signaling and leads to multiorgan inﬂammation reminiscent
of Tgfb1 null mutants, suggesting that LLC formation is critical to
activate L-TGF  [22]. On the other hand, inactivation of ﬁbrillin-1,
an LTBP-anchoring matrix protein in microﬁbrils that is mutated in
Marfan syndrome [23,24], leads to excess release of active TGF
and thereby increases the risk of aortic aneurisms [25,26]. Fib-
rillin also tethers several BMP  prodomains and associated mature
ligands, including BMP2,4,5,7,10 and GDF5 [27–29]. Presumably,
these ligands are deposited in ECM for storage and release upon
demand.
In bone marrow, L-TGF  is activated by v8 integrin of non-
myelinating Schwann cells of the autonomic nervous system that
are in direct contact with lineage-negative hematopoietic stem
cells. Although HSCs produce L-TGF,  they depend on these novel
niche cells as a source of active TGF to maintain their quiescence
and long-term repopulation potential [30]. Analogous interactions
with the microenvironment may  also control the bioavailability of
active TGF in other stem cell compartments. Alternatively, inte-
grins v8 and v86 can activate L-TGF  that is presented by the
spring-shaped transmembrane protein GARP at the plasma mem-
brane, e.g. in immunosuppressive T regulatory cells [31,32] (Fig. 1B).
Association of LAP with GARP involves Cys33 [32], indicating that
some anti-inﬂammatory TGF signals attributed to activation by
LTBPs may  depend on GARP. Images of LAP and integrins bound
to LTBP or GARP obtained by negative stain electron microscopy
support the model that integrins pull on LAP subunits to activate
L-TGF  that is held in place by LTBP or GARP [32]. However, the
role of precursor cleavage remains obscure because the structure
of the loop with the PC cleavage site in crystals of L-TGF  was
disordered (Fig. 1A, stippled line). Since TGF precursor can be acti-
vated even in its uncleaved form after acidiﬁcation in vitro [33], it
would be interesting to know why precursor cleavage is necessary
to overcome latency in vivo.
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Fig. 1. Regulation of TGF bioavailability. (A) Maturation of TGF and related ligands requires proteolytic cleavage of the precursor dimer by Furin or a related PC (scissors).
Mature  TGF, Activin, GDF8 and GDF11 can remain bound to cleaved prodomains that are attached to the indicated LTBP for storage in extracellular matrix (ECM). Integrin
heterodimers that bind an RGD motif in the prodomain release mature TGF from the latent complex to liberate receptor-binding epitopes from a straightjacket formed
by  the ﬁrst -helix (1) and the latency lasso (black) of the prodomain. Note that LTBP2 and 3 can also bind and inhibit PCSK5. (B) Alternatively, L-TGF is linked to the
spring-shaped cell-surface molecule GARP. (C and D) The Golgi protein ESL-1 (C), which has 16 cysteine-repeats that can be shed and further processed by PC-like activities,
and  the EMI  domain of the trimeric matrix protein Emilin-1 (D) can inhibit processing of the TGF precursor, but their binding sites in TGF have not been mapped in detail.
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n.3. Roles of prodomains in secretion and latency of TGFˇ-related
igands
How prodomains of other TGF family members inﬂuence
he bioavailability of mature ligands is less clear. Generally,
rodomains assist in the folding of the precursor in the endoplasmic
eticulum [34,35]. Mutagenesis of TGF and Inhibin- revealed that
ecretion and/or stability depend on the interface between mature
igand and six hydrophobic residues in the C-terminal half of the
1-helix of the prodomain [36]. Only Nodal, GDF6, GDF15 (MIC-1)
nd AMH lack several of these highly conserved residues (Fig. 2)
nterestingly, the same ligands can adopt an active conformation
ndependently of their prodomains [37–41]. Which of these and
ther prodomains may  confer latency remains to be systematically
nalyzed. In TGF1, latency depends on covalent homodimeriza-
ion of LAP by Cys223 and Cys225 [42]. Analogous regions in BMP
nd Nodal prodomains lack cysteines [16], explaining perhaps why
hey do not inhibit binding of mature ligand to receptors [43,44].
MP  and Nodal prodomains also lack cysteines in the 1-helix to
ind LTBPs or analogous tethering molecules. By contrast, such cys-
eines can be found in Inhibin-, GDF8 (myostatin), GDF11, and
MP8 (Fig. 2). GDF8 and GDF11 also form latent complexes [45,46]
nd interact with LTBP2,3 [47,48], suggesting that their activation
ay  follow the paradigm of L-TGF.  Alternatively, the straight jack-
ts that confer latency to GDF8 and GDF11 can be removed by
roteolysis. A peptide bond at the C-terminus of the second con-
erved -helix in the prodomain of GDF8 proximal to Asp76 can be
leaved by metalloproteases of the BMP1/Tolloid family, leading to
he release of mature ligand [49]. BMP1/Tolloid proteases recog-
ize the sequence Y/H-X-Y/F-X-X′D [50]. A similar motif exists inthe prodomains of all TGF family members that form latent com-
plexes, including TGF1–3, BMP10, GDF2, GDF5 and GDF15, but not
in others (Fig. 2), and BMP10 can be cleaved by BMP1 [29]. Cleav-
age by BMP1/Tolloid thus may  be a common alternative strategy to
overcome latency.
1.4. Mutations in the prodomains of TGF  ˇ family members
associated with human diseases
Human mutations in prodomains of TGF and related precur-
sors are found in several diseases. In Camurati-Engelmann disease,
a rare genetic disorder characterized by progressive thickening
of bones, mutations in the LAP of TGF cluster around cysteines
223 and 225 and destabilize the SLC [51–54]. Other skeletal mal-
formations such as shortening of the second and third ﬁngers
(brachydactyly type C) and misshapen phalanges are seen in fam-
ilies with a substitution of S204 by arginine in GDF5 [55], and
BMP4 prodomain was  found mutated in patients with cleft lips
[56]. Premature decline in ovarian follicle formation in women
is linked to mutations in the BMP15 prodomain [57], and mis-
sense mutations in the prodomain of AMH  occur in patients with
persistent Müllerian duct syndrome [58,59]. Finally, mutations
in the prodomain of NODAL associate with congenital left-right
patterning defects of the heart outﬂow tract. In particular, dele-
tion of residues R234 to P241 destroys the NODAL precursor
cleavage motif, whereas an E203K substitution may  be part of a
co-receptor binding site [60–62]. However, to interpret the pheno-
types associated with speciﬁc mutations, a better understanding of
the normal functions of prodomains and of their processing will be
needed.
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TGF1po    LSTCKTIDMELVKRKRIEAIRGQILSKLRLASPPSQGDV---------------------PP---------GPLPEAVLALYNSTRDRVAGESVEPE 67
TGF1hu    LSTCKTIDMELVKRKRIEAIRGQILSKLRLASPPSQGEV---------------------PP---------GPLPEAVLALYNSTRDRVAGESAEPE 67
TGF2     SLSTCSTLDMDQFMRKRIEAIRGQILSKLKLTSPPEDY-----------------------PE--------PEEVPPEVISIYNSTRDLLQEKASRRA 67
TGF3   ..SLSTCTTLDFGHIKKKRVEAIRGQILSKLRLTSPPE-------------------------PT-------VMTHVPYQVLALYNSTRELLEEMHGERE 68
GDF8   ..EGLCNACTWRQNTKSSRIEAIKIQILSKLRLETAPNISKDVIRQLL---------------PK---------APPLRELIDQYDVQRDD-SSDGSLED 85
GDF11  ..PDGCPVCVWRQHSRELRLESIKSQILSKLRLKEAPNISREVVKQLL---------------PK---------APPLQQILDLHDFQGDALQPEDFLEE 108
Inh_bA ..CALAALPKDVPNSQPEMVEAVKKHILNMLHLKKRPDVTQPV--------------------PK---------AALLNAIRKLHVGKVGENGYVEI--- 83
Inh_bB ..CGGFRRPEELGRVDGDFLEAVKRHILSRLQMRGRPNITHAV--------------------PK---------AAMVTALRKLHAGKVREDGRVEI--- 95
Inh_bC ..CGG--PTLELESQRELLLDLAKRSILDKLHLTQRPTLNRPV--------------------SR---------AALRTALQHLHGVPQGALLEDNR--- 75
Inh_bE ..CGG--SKLAPQAERALVLELAKQQILDGLHLTSRPRITHPP--------------------PQ---------AALTRALRRLQPGSVAPGN------- 68
Inh_a    ------CQGLELARELVLAKVRALFLDAL---GPPAVTREGGD------------------PG---------------VRRLPRRHALGGFTHRGSEP 56
BMP3     -----------ERPKPPFPELRKAVPGDRTAGGGPDSELQ---------------------PQ---------DKVSEHMLRLYDRYSTVQAARTPGSL 57
GDF10    --------SHRAPAWSALPAAADGLQGDRDLQRHPGDAAATLG------------------PS-------AQDMVAVHMHRLYEKYSRQGARPGG--- 62
BMP15   MEHRAQMAEGGQSSIALLAEAPTLPLIEEL-LEESPGEQPRK--------------------PR-------LLGHSLRYMLELYRRSADSHGHPRENRT 71
GDF9   ..SAELESGAMPWSLLQHIDERDRAGLLPALFKVLSVGRGGSPRLQ-----------------PD---------SRALHYMKKLYKTYATKEGIPKSNRS 84
GDF1     ---------------PVPPGPAAALLQALGLRDEPQGA-----------------------PR--------LRPVPPVMWRLFRRRDPQETRSGSRRT 52
GDF3     --------------------QEYVFLQFLGLDKAPS-------------------------PQ-------KFQPVPYILKKIFQDREAAATTGVSRDL 46
BMP10  ..LFGDVFSEQDGVDFNTLLQSMKDEFLKTLNLSDIPTQDSAKVDP-----------------PE--------------YMLELYNKFATDRTS------ 77
GDF2   ..GVPGGGLPEHTFNLKMFLENVKVDFLRSLNLSGVPSQDKTRVEP-----------------PQ--------------YMIDLYNRYTSDKSTT----- 81
BMP2   ..FAAASSGRPSSQPSDEVLSEFELRLLSMFGLKQRPT-------------------------PS-------RDAVVPPYMLDLYRRHSGQPGSPAPDHR 75
BMP4   ..IQGHAGGRRSGQ-SHELLRDFEATLLQMFGLRRRPQ-------------------------PS-------KSAVIPDYMRDLYRLQSGEEEEEQIHST 83
BMP5     DNHVHSSFIYRRLRNHERREIQREILSILGLPHRPR-------------------------PF---SPGKQASSAPLFMLDLYNAMTN---EENPEES 67
BMP7   ..DNEVHSSFIHRRLRSQERREMQREILSILGLPHRPR-------------------------PH---LQGKH-NSAPMFMLDLYNAMAV---EEGGGPG 70
BMP6   ..SPQSSSGFLYRRLKTQEKREMQKEILSVLGLPHRPRPLHGLQQPQPPALRQQEEQQQQQQLPRGEPPPGRL-KSAPLFMLDLYNALSADNDEDGASEG 135
BMP8   ..GLRPPPGCPQRRLGARERRDVQREILAVLGLPGRPR-------------------------PRAPPAASRLPASAPLFMLDLYHAMAGDDDEDGAPAE 77
GDF5   ..TVTPKGQLPGGKAPPKAGSVPSSFLLKKAREPGPPREPKEPFRPPPIT-------------PH-------------EYMLSLYRTLSDADRKGGNSSV 165
GDF7   ..LRAAGAGPVRSPGGGGGGGGGGRTLAQAAGAAAVPAAAVPRARAARRAAGSGFRNGSVV--PH-------------HFMMSLYRSLAGRAPAGAAAVS 92
LEFTY1    --------------LTGEQLLGSLLRQLQLKEVPTLDRADMEELVI--------------PT---------HVRAQYVALLQRSHGDRSRGKRFSQS 60
LEFTY2    --------------LTEEQLLGSLLRQLQLSEVPVLDRADMEKLVI--------------PA---------HVRAQYVVLLRRSHGDRSRGKRFSQS 60
NRTN   ..SHRLGPALVPLHRLPRTLDARIARLAQYRALLQGA--------------------------PD------------AMELRELTPWAGRPPGP------ 64
ARTN   ..APREGPPPVLASPAGHLPGGRTARWCSGRARRPPP--------------------------QP------SRPAPPPPA-------------------- 55
PSPN     --------------------------WGPDARGVP--------------------------VA-------DGEFSSEQVAKAGGTWLGTHR------- 32
-GDNF ---------FPLPAGKRPPEAPAEDRSLGRRRAP-----------------------FALSS----DSNMPEDYPDQFDDVMDFIQATIKRLKRSPD 61
-GDNF   ---------FPLPA------------------------------------------------------NMPEDYPDQFDDVMDFIQATIKRLKRSPD 61
Nodal    -------------------TVATALLRTRGQPSSPS-------------------------PL-------------AYMLSLYR-------------- 27
GDF6   ..RKEGKMQRAPRDSDAGREGQEPQPRPQDEPRAQQPRAQEPPGRGPRVV-------------PH-------------EYMLSIYRTYSIAEKLGINASF 96
GDF15     ---------------------------LSLAEASRASFPG--------------------PS-------ELHSEDSRFRELRKRYEDLLTRLRANQS 43
AMH    ..LGAWLRDPGGQRLVVLHLEEVTWEPTPSLRFQEPP--------------------------PG-------GAGPPELALLVLYPGPGPEVTVTRAGLP 164
1 2
Fig. 2. Amino-terminal sequences of TGF-related prodomains. Numbers indicate amino acid positions relative to the last residue of cleaved signal sequences. Cys33 (fourth
residue in the 1-helix of TGF1) and analogous cysteines are shaded pink. Conserved hydrophobic residues required for an interaction of the straightjacket with the mature
domain are highlighted yellow. An arrow marks the peptide bond proximal to the partially conserved residue Asp76 (red) of GDF8 that is hydrolyzed by Bmp1/Tolloid to
overcome latency. Some BMP  ligands in Drosophila, mammalian Lefty1 and -2 and GDNF have instead a PC motif at this position (green). Both () and () GDNF prodomains
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. Roles of proprotein convertases in TGF signaling
.1. Processing by partially overlapping PC activities
Compared to the regulation of TGF latency, relatively little is
nown about the mechanisms that control precursor processing.
ngineered mutations in cleavage sites usually give rise to secreted
recursors that can act as dominant negative mutants at least when
verexpressed [63–65], suggesting that proteolytic maturation is
ndispensable. In general, TGF and related precursors are only par-
ially cleaved in most cell lines and tissues examined, but the rates
f cleavage vary, sometimes in a species-speciﬁc manner. Dramatic
ifferences in the steady state levels of mature BMP15 can explain
ifferent ovulation quota in mice compared to man [66]. The true
xtent of cleavage and its regulation cannot be estimated, though,
ithout taking into account the turnover of mature forms by endo-
ytosis or other mechanisms [40,67]. In other words, low steady
tate concentrations of mature form of a given ligand are no proof
hat precursor processing is inefﬁcient.
Cleavage site sequences considerably diverge among TGF-
elated precursors and across species [68]. The only conserved
eature consists of an RXXR consensus sequence, with X corre-
ponding to any amino acid. The RXXR motif ﬁts the minimal
ecognition motif of Furin (SPC1, PCSK3) and of the related serine
roteases PACE4 (SPC4, PCSK6), PCSK5 (SPC5, PC5/6) and PC7 (SPC7,
PC, PC8, PCSK7) [69–72]. In mammals, these and ﬁve additional
nzymes represent a family of eukaryotic proprotein convertases
PC) of the subtilisin/kexin type (PCSK) that share similar catalyticut in ()GDNF. Alignments are from Ref. [16]. Dashes indicate gaps, dots represent
domains with bacterial subtilases [reviewed in 73]. A crystal struc-
ture of Furin and homology models of related PCs are available
[73–75, for a discussion of their therapeutic targeting, see 76]. Furin,
Pace4, Pcsk5 and PC7 are widely expressed in most tissues and cell
lines [70]. Nevertheless, unique phenotypes of knockout mice sug-
gest that functional redundancy is not unlimited [reviewed in 73,
77–82]. Non-redundant functions may  reﬂect tissue-speciﬁc differ-
ences in relative expression levels, distinct trafﬁcking itineraries as
well as subtle differences in the active sites of individual PCs.
Of many possible PC substrates, only few have been validated
in vivo. The ﬁrst study linking TGF processing to PCs showed
that precursor cleavage is inhibited in cells treated with the
pan-PC inhibitor decanoyl-RVKR-chloromethylketone and in the
Furin-deﬁcient LoVo colon carcinoma cell line. Conversely, overex-
pression of Furin or treatment with recombinant Furin in cell-free
assays stimulated TGF precursor cleavage [83]. Independently,
a screen for candidate BMP  convertases identiﬁed Furin, Pace4,
Pcsk5 and the novel PC7 in multiple tissues that are patterned
by BMP  signals [84]. Overexpression in Xenopus and in tissue cul-
ture cells conﬁrmed that Furin, PACE4, Pcsk5 and PC7 can promote
Bmp4 processing, whereas the Nodal precursor was cleaved by
Furin and PACE4 [67,85]. Dissecting the contributions of endoge-
nous PCs to TGF signaling turned out to be more complicated
owing to functional redundancy. Another limiting factor to vali-
date the role of PCs in BMP  processing is the lack of reagents
to reliably detect cleaved substrates of interest at physiological
expression levels. Genetic analysis showed that neither the loss of
Furin, Pace4,  Pcsk5 or PC7 alone abolished known functions of Bmp4
D.B. Constam / Seminars in Cell & Develo
Fig. 3. Summary of PC expression patterns observed in mouse embryos. While Pace4
mRNA speciﬁcally marks the extraembryonic ectoderm lineage at all stages between
embryonic days E5.5-7.5, Furin is also transiently expressed until E5.5 in visceral
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rndoderm (purple). PC7 is the ﬁrst PC expressed in the epiblast and its derivatives,
tarting at E6.5. Pcsk5 is speciﬁcally induced in cardiac mesoderm by E7.5. By this
tage, epiblast derivatives also express Furin, albeit at low levels.
r Bmp2 in mouse embryos [77,78,81,82], and mature Bmp4 was
till detected in Furin;Pace4 double mutants [86]. However, com-
ined absence of Furin and Pace4 severely inhibited the induction of
odal target genes [86]. By contrast, combined inactivation of Furin
nd PC7 selectively blocked BMP, but not Nodal signaling (D.B.C.,
npublished). Concurring with these observations, activation of
odal-related Xnr1, Xnr2 and Xnr3 in Xenopus required maternal
Pace4 [87,reviewed in 88], whereas combined inactivation of xFu-
in, xPCSK5 and xPC7 was necessary to abolish the processing of
roBmp4 [89]. Exogenous Pcsk5 can also cleave mouse Nodal [86].
owever, in the mouse embryo, Pcsk5 normally is only induced
uring late gastrulation, explaining why Nodal processing relies
n Furin and Pace4 [90] (Fig. 3). Several Furin-like proteases also
xist in Drosophila,  including DFur1, DFur2 and Amon, and DFur1
nd DFur2 cleave the BMP4/2 homolog Dpp in S2 cells [68]. Func-
ional overlap among convertases may  explain why  PCs have not
et emerged from genetic screens for modiﬁers of BMP  signaling in
hese or other invertebrates.
.2. Flanking sequences do not predict which PCs will recognize
n RXXR motif
PC recognition sequences that contain an additional basic
esidue (either RXRXXR or RXK/RR) tend to be more rapidly cleaved
han the minimal RXXR motif, and RXXR can even entirely resist PC7
n some contexts [89,91], but not in others [72]. Which PCs cleave
 given TGF family member cannot be predicted. In adult mice,
eletion of a conditional Furin allele by CD4-Cre in T lymphocytes
mpairs the induction of T regulatory cells, leading to autoimmu-
ity and inﬂammatory bowel disease due to severe inhibition of
GF1 precursor processing [92]. Why  cleavage of the sequence
SRHRR↓ALDT in the TGF1 precursor is not rescued by other PCs
s unknown. Functional redundancy among PCs is also limited in
he case of GDF5 processing: Loss of Pcsk5 causes late gestation
henotypes that recapitulate defects seen in Gdf11 mutants, includ-
ng homeotic transformations of vertebrae, caudal truncations and
enal agenesis [80,81,93]. One study reported that PCs other thanpmental Biology 32 (2014) 85–97 89
Pcsk5 also fail to cleave GDF11 in vitro, and this was attributed to a
conserved Asn residue (N) in the cleavage motif TKRSRR↓NLGL [80].
However, others reported that GDF11 can also be cleaved ex vivo
by PACE4 or by soluble Furin [47,48], and processing of the similar
sequence SARIRR↓NAKG in the Bmp10 precursor which carries Asn
at an analogous position relies mainly on Furin, at least in cultured
primary hepatocytes [94]. These examples show that more work is
needed to decipher the logic that governs the cleavage speciﬁcities
of individual PCs in vivo.
2.3. Regulation of PC trafﬁcking and autoactivation
In order to be cleaved, substrates must colocalize at some
point with active forms of their convertases. The regulation of
this colocalization before or after exocytosis emerges as a critical
determinant of substrate speciﬁcity, since each PC has its unique
trafﬁcking itinerary and follows a distinct program of zymogenic
maturation [95]. Substrates also travel on distinct secretory and
endocytic routes, and their cleavage sites may  be masked at some
steps along the journey. The trafﬁcking of PCs can be summarized
as follows [for in-depth review, see 95]:
• Furin, PC7 and a long splice variant (isoform B) of PCSK5 have
trans-membrane and cytosolic domains that enable the cycling
between the trans-Golgi network (TGN) and the plasma mem-
brane through endocytic pathways [91,96–99]. Alternatively, a
fraction of PC7 can reach the plasma membrane by a TGN-
independent route [100].
• Shedding by unidentiﬁed proteases can give rise to soluble forms
of Furin and PCSK5B [101–103].
• PACE4 and a short splice variant of PCSK5 (isoform A) are soluble
by default, but can be thethered to the cell surface by HSPGs [104].
• All PCs derive from inactive zymogens; folding into an active
conformation depends on their N-terminal prosegments. Auto-
cleavage of the prosegments enables translocation to the Golgi
apparatus, but is not sufﬁcient to unmask the active site [70].
• Liberation of Furin from its inhibitory prosegments requires a sec-
ondary autocleavage that is regulated by endosomal acidiﬁcation
[105–107]. By contrast, removal of the prosegment of PCSK5A
involves an intermolecular cleavage at the cell surface that is
induced by cAMP [104].
However, these conclusions are based on overexpression stud-
ies. The distribution of endogenous PCs has remained obscure
owing to the lack of speciﬁc antibodies. An immunoelectron
microscopy analysis by Bendayan and colleagues is a noteable
exception, which detected large amounts of Furin at the plasma
membrane of capillary endothelial cells, and in endosomes and
basolateral membrane of intestinal and proximal renal tubule
epithelial cells, in addition to Golgi stacks and endosomes [99].
Endosomes and the Golgi apparatus also contain Furin in liver
hepatocytes, but co-localization with TGN markers has only been
reported with overexpressed HA-tagged Furin [99].
2.4. Extracellular or intracellular precursor processing?
When and where a PC substrate matures also depends on its
own trafﬁcking. TGF itself is generally believed to mature intra-
cellularly. The TGF1 precursor acquires complex carbohydrate
modiﬁcations during exocytosis, indicating transit through the TGN
[33]. Pioneering studies detected mature TGF alongside uncleaved
precursor in conditioned media as well as in lysates of COS-1 and
CHO cells [35,108], whereas in a human erythroleukemia cell line
the mature form was only found extracellularly [109]. The release
of mature form was  blocked by pharmacological inhibitors of endo-
somal acidiﬁcation such as chloroquine or monensin [109,110].
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herefore, and since overexpressed Furin accumulates in the TGN,
t is widely accepted that TGF matures in a late Golgi compart-
ent. One caveat is that inhibitors of endosomal acidiﬁcation also
lock endocytosis of TGF [111] as well as the endocytic recycling
nd shedding of Furin [62,105]. Mature TGF thus will disap-
ear in lysates of chloroquine-treated cells regardless of whether
rocessing normally takes place before or after TGN transit. Since
he mere presence of mature TGF in cell lysates does not allow to
iscern whether it was produced in the TGN or at the cell surface
r even in endosomes, the case for intracellular processing in our
iew is not settled. In any case, in systems where the majority of
ecreted TGF is unprocessed, a more relevant question might be
hether or not this uncleaved pool can still be used at a later stage
nd if so, how.
Certain prodomains may  be impervious to cleavage by intra-
ellular PCs. In GDNF, which provides neurotrophic support to
opaminergic neurons, alternative splicing gives rise to the iso-
orms  and  that differ by 27 residues in their short prodomains
Fig. 2). Mature  and  GDNF accumulate together with their
recursors in conditioned media of CHO ﬁbroblasts and of neu-
ons derived from PC12 pheochromocytoma cells. By contrast, only
ncleaved forms are found in cell lysates, and immunostaining
f unpermeabilized cells shows that these accumulate at the cell
urface [112]. Immunoelectron microscopy also detected ()pro-
DNF in the Golgi, whereas ()pro-GDNF was primarily found in
esicles of the regulated secretory pathway. This suggests that sor-
ing of pro-GDNF to distinct exocytic compartments is regulated
y prodomain sequences. No intracellular cleavage was  detected,
ven though the cleavage motif IKRLKR↓SPDK of GDNF perfectly
ts a consensus PC recognition sequence.
The importance of prodomain sequences in localizing precursor
leavage is underscored by studies on GDF15. Uncleaved GDF15
recursor is secreted in copious amounts by prostate cancer cells
nd other tumors, but then matures extracellularly as shown by
ulse-chase analysis in undifferentiated U937 monocytoid cells
41,113]. The release of mature GDF15 into the circulation predicts
n increased risk of metastasis in human prostate carcinoma [114].
t also leads to systemic effects such as anorexia and weight loss
115]. On the other hand, high levels of uncleaved GDF15 precursor
ound to extracellular matrix through its prodomain correlate with
ncreased risk of relapse after surgery [116]. These ﬁndings suggest
hat storage of GDF15 precursor in the ECM and the regulation of
ts extracellular maturation are likely clinically relevant.
.5. Speciﬁc binding proteins inhibit maturation of selected PC
ubstrates
Cleavage of the TGF precursor can be inhibited by the inter-
cting factors E-selectin ligand-1 (ESL-1) or Emilin-1 (Fig. 1C, D).
SL-1 copuriﬁed speciﬁcally with uncleaved TGF1 precursor from
HO cell conditioned medium in a disulphide-linked complex dis-
inct from LLC [117]. ESL-1 is widely expressed and required for
ormal chondrocyte differentiation and skeletal growth [118]. Loss
f ESL-1 in growth plates enhanced pSmad2,3 signaling, whereas
verexpression in cultured cells had the opposite effect. Binding
o ESL-1 slowed down TGF precursor cleavage by Furin in trans-
ected cells and in cell-free assays. Owing to its localization in the
olgi, ESL-1 thus has been proposed to interfere with intracellular
GF processing [118]. Interestingly, ESL-1 is itself a PC substrate,
nd its shedding by a Furin-like convertase generates a soluble form
hat interacts with heparan sulfate proteoglycans (HSPG) at the cell
urface [119,120]. It might be interesting to test, therefore, whether
SPGs inﬂuence the localization or processing of an ESL-1/proTGF
omplex.
Uncleaved TGF, but not latent or mature forms also associate
ith Emilin-1 [121], a protein in the ECM of elastic ﬁbers aroundpmental Biology 32 (2014) 85–97
blood vessels [122]. Deletion of Emilin-1 in mice leads to vasocon-
striction and hypertension, which can be rescued by removing one
copy of Tgfb1. Biochemical analysis in transfected cells revealed
that Emilin-1 directly binds the precursor and blocks its proteoly-
tic maturation. By contrast, signaling of recombinant mature TGF
was not inhibited, suggesting that Emilin-1 selectively acts on the
precursor. Emilin-1 equally inhibited TGF precursor processing
and signaling regardless of whether it was coexpressed with TGF
in the same cells or provided in trans. This implies that active TGF
was mainly derived from extracellular precursor in this experi-
mental setup. Ectopic expression of ESL-1 or Emilin-1 in Xenopus
also interfered with the activation of Nodal signaling [118,121].
Other proteins that bind speciﬁc precursors to inhibit their proteo-
lytic maturation may  include LTBP2 and LTBP3. They attenuated
processing of GDF11 when overexpressed in HEK293 cells, and
extracellular GDF11 is mainly stored as an uncleaved precursor in
mouse hind limb skeletal muscle [47,48]. In addition, recent genetic
studies in Drosophila and in mammalian cells revealed that intra-
cellular processing of the unrelated Notch precursor is inhibited by
the novel Notch-interacting factor Botch [123]. However, analogous
endogenously expressed inhibitors of Nodal or BMP processing
remain to be identiﬁed.
2.6. Live imaging reveals paracrine activity of extracellular Nodal
convertases
Genetic analysis of PC functions in mice suggests that Pace4
and Furin act extracellularly to regulate TGF signals mediated by
Nodal. In chordates, Nodal proteins induce mesoderm and endo-
derm formation and determine visceral left-right asymmetry [124].
In addition, deletion of Nodal in mouse embryos leads to pre-
mature neural gene expression at the expense of pluripotency
markers such as Oct4 and Nanog [125–127], a phenotype that can
be recapitulated in human embryonic stem cells by pharmacolog-
ical inhibition of Nodal/Activin receptors [128–130]. Deletion of
Nodal also induces precocious differentiation of germ cells in male
embryonic gonads [131], and combined inhibition of Nodal/Activin
receptors or germ cell-speciﬁc ablation of Smad4 drives male germ
cells into meiosis, suggesting that autocrine Nodal signaling coop-
erates with related ligands to promote male sexual differentiation
[132,133]. A growing body of literature also links ectopic Nodal
signaling to cancer cell invasiveness in testicular and several other
tumors [reviewed in 1,131].
In the early mouse embryo, Nodal expression is primarily
required in epiblast cells that derive from the inner cell mass of
the blastocyst [134]. A ﬁrst hint that Nodal matures exracellularly
came from the observation that Furin and Pace4 during gastrulation
are only transcribed in extraembryonic lineages (Fig. 3). Removal of
this extraembryonic source in genetically mosaic chimeras and in
cultured explants inhibited autocrine Nodal functions within the
epiblast [86]. Pulse-chase experiments in transfected cells later
conﬁrmed that Nodal matured after the appearance of the pre-
cursor in conditioned medium [40]. However, tissue culture cells
lack speciﬁc regulatory factors that may  control Nodal trafﬁcking
in vivo. In particular, they do not express Cripto or the related core-
ceptor Cryptic which normally associate with Nodal and its type
I signaling receptor ActR1B [reviewed in 135]. Cotransfection of
Cripto drastically reduces the solubility of Nodal precursor [62].
Furthermore, reconstitution experiments with wild-type or mutant
forms of Cripto revealed that a glycosyl-phosphatidylinositol (GPI)
modiﬁcation is indispensable for membrane anchoring, and that
substitution of the GPI signal by a transmembrane domain blocks
ActR1B/Smad2,3 signaling by Nodal [136]. Smad signaling is also
abolished if the GPI anchor is disrupted by a C-terminal Flag epi-
tope, even though Flag-tagged Cripto can still bind both Nodal and
ActR1B [137, and our unpublished observation]. So why is the GPI
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nchor so important? Biochemical analysis revealed that Cripto
ecruits uncleaved Nodal to lipid rafts and thereby facilitates access
f the mature form to signaling receptors at the limiting mem-
rane of early endosomes [62,138]. Independently, Cripto can bind
he Nodal convertases through a conserved sequence ﬂanking their
atalytic domains. These observations suggest that GPI-anchoring
f Cripto directs the proteolytic maturation of Nodal to mem-
rane domains that have access to signaling-competent endosomes
reviewed in 139].
An important prediction of this model was that Pace4 and Furin
n vivo would have to act at a certain range to directly activate
 functionally relevant pool of Nodal at the surface of distant
piblast cells (Fig. 4A) [140]. Conﬁrming this prediction, expres-
ion of transgenic GFP-tagged Furin or Pace4 speciﬁcally in the
xtraembryonic compartment revealed GFP ﬂuorescence reaching
he epiblast through the extracellular space [141] (Fig. 4B). Res-
ue of Nodal signaling in Furin−/−;Pace4−/− double mutant embryos
onﬁrmed that these transgenes were functional. Furthermore, to
irectly image paracrine PC activity at the cell surface, a Cell-Linked
ndicator of Proteolysis (CLIP) was developed. This reporter sub-
trate consists of secreted eCFP and GPI-anchored citrine, fused by
 PC cleavage site (Fig. 4C). Proteolytic removal of eCFP revealed
ndogenous PC activity in the epiblast lineage, and this activity was
iminished in Furin−/−;Pace4−/− double mutants both in vivo and
n embryo cultures [90]. On the other hand, paracrine PC activ-
ty in the epiblast was signiﬁcantly rescued if transgenic FurinGFP
r Pace4GFP was added back speciﬁcally from the extraembry-
nic microenvironment [141]. These observations demonstrate a
aracrine function for PCs. Unexpectedly, live imaging detected
ace4GFP and shed FurinGFP on opposite sides of the polarized
piblast epithelium, potentially adding another layer of complex-
ty to the regulation of Nodal processing. Equally surprising, CLIP
maging revealed an additional PC-like activity in the epiblast of
urin−/−;Pace4−/− double mutants that was inhibited if embryos
ere removed from the uterus [141]. Whether this activity derives
rom a maternal source, or whether loss of Furin and Pace4 leads to
ompensatory upregulation of other family members such as Pcsk5
r PC7 remains to be determined.
. Precursor cleavage and morphogenetic signaling
.1. Impact of precursor cleavage on Nodal activity and stability
Removal of the prodomain of TGF is essential to unmask
eceptor binding epitopes. By contrast, the uncleaved prodomain
f Nodal does not prevent precursor binding to type I or type II
ignaling receptors either in transfected cells or in cell-free assays
43]. A PC-resistant mutant Nodal precursor that was  expressed
t physiological levels from a knock-in allele also retained signiﬁ-
ant activity in vivo and stimulated e.g. the expression of Furin and
ace4. This may  reﬂect the fact that the Nodal prodomain lacks 3 of
he 5 conserved hydrophobic residues in the N-terminal 1-helix
hat are all essential for TGF1 latency (Fig. 2). Also the stabiliz-
ng dimerization interface found in TGF1 LAP is not conserved
16,54]. So why is precursor cleavage still required for normal Nodal
unction? The answer to this unresolved question may  be linked
o a role of the prodomain in precursor trafﬁcking. If proteoly-
ic maturation is inhibited, Nodal is stabilized at the cell surface,
hereas cleavage facilitates access to signaling receptors in early
ndosomes [62,138]. How the uncleaved prodomain attenuates
ndocytosis is unclear, but since it can either bind Cripto or the
ysosomal sorting receptor Sortilin and perhaps other cell surface
olecules, one possibility is that proteolytic maturation inﬂuences
he choice between alternative interactions with distinct trafﬁcking
olecules [62,142]. In keeping with such a model, ex vivo studiespmental Biology 32 (2014) 85–97 91
on Nodal processing highlighted a role for precursor cleavage in
accelerating ligand turnover [40,67].
There may  be important species differences, though, since apart
from mouse Nodal, only one related protein in Xenopus has been
shown to retain signiﬁcant activity after mutation of the PC cleav-
age motif [65,143]. Nodal prodomains and mature ligands from a
given species also differ in their potential to promote long range
signaling, as shown by comparisons of Cyc, Sqt and Spw activities
in zebraﬁsh [144–146]. The short signaling range of Cyc has been
linked to a lysosomal targeting motif in the prodomain, suggesting
that this prodomain promotes ligand turnover, rather than inhibi-
ting it [61]. In good agreement, extracellular fractions of deyolked
zebraﬁsh blastoderms accumulated much higher levels of Sqt than
of Cyc when equal amounts of mRNAs were injected at the 1-cell
stage [147]. Similar analysis of correctly processed GFP- or Den-
dra2 fusions of Sqt or Cyc again detected higher levels of Sqt. A
chase of extracellular Sqt-Dendra2 after photoconversion revealed
a half life of 95 min  [147]. This is comparable to the decay rate of
mature mouse Nodal in cultured HEK293T cells, but 3 times faster
than that of its precursor [40]. Thus, the high steady state concen-
tration of extracellular mature Sqt points to an increased rate of
proteolytic processing compared to that of mouse Nodal in tissue
culture.
3.2. Why  is extracellular DPP in wing imaginal discs mostly
immobile?
In Drosophila,  patterning and growth of larval wing imaginal
discs are coordinated by the morphogen Decapentaplegic (DPP), the
homolog of vertebrate BMP2 and BMP4. Whether and how a DPP
activity gradient is regulated at the level of precursor processing
or by its inﬂuence on ligand turnover is unclear. DPP is secreted
by a stripe of cells along the anteroposterior compartment bound-
ary and directly induces different target genes at distinct threshold
concentrations by activating complexes of the type I and II recep-
tors Thickveins (TKV) and Punt in distant cells [reviewed in 148].
While TKV is expressed at elevated levels at the periphery of
the wing primordium to sensitize cells to DPP, downregulation of
TKV in the central region facilitates the spreading of DPP activity
[149,150]. To test whether receptor-mediated endocytosis shapes
a morphogen gradient, a DPP-GFP fusion protein was expressed in
the dpp stripe. Live imaging outside the dpp stripe revealed DPP-
GFP ﬂuorescence both between cells and in endosomes containing
TKV [151,152]. Biochemical analysis indicated that the extracellu-
lar fraction was  processed and short-lived, consistent with rapid
clearance by receptor-mediated endocytosis [151,152]. However,
whether endocytosis restricts the movement of DPP from cell to
cell, or whether it promotes gradient formation by a process of pla-
nar transcytosis is still debated [7,153–155]. Deﬁnining the role
of endocytosis remains difﬁcult because disruption of this process
will not only affect TKV, but also the trafﬁcking of DPP coreceptors,
convertases and other regulatory factors. It also remains a challenge
to discern what deﬁnes the mobile fraction of DPP that forms the
activity gradient. Immunostaining of cross-sectioned third instar
imaginal discs revealed that extracellular DPP-GFP and endoge-
nous DPP primarily ﬁll up the lumen above the apical surface of the
wing disk epithelium, where free diffusion will rapidly suppress
any gradient [156]. By contrast, the graded extracellular signal on
the basolateral side is weak, and a recent estimate suggests that
less than 3% of the total DPP-GFP within the wing disk epithelium is
free to move [155]. Since the mobile fraction is so underrepresented
in the total pool of DPP-GFP, it remains technically challenging to
ascertain whether it corresponds to mature DPP or a processing
intermediate.
A related question is why  the mobile fraction of DPP is so small
[155]. Deletion or overexpression of DPP receptors in clones of cells
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Fig. 4. Analysis of paracrine PC functions. (A) When bound to Cripto (brown), mature Nodal (orange) and cleaved prodomain (blue) can access signaling-competent membrane
domains  (yellow), whereas Cripto-independent maturation promotes lysosomal targeting (trash). To activate membrane-bound Nodal in epiblast cells (gray), Pace4 and a
shed  form of Furin (purple) have to travel a certain distance from extraembryonic ectoderm. (B) Transgenic FurinGFP and Pace4GFP expressed in extraembryonic ectoderm
(EXE) reach epiblast cells from the apical and basolateral side, respectively, and can rescue Nodal signaling in Furin−/−;Pace4−/− double mutants. Although epiblast cells (EPI)
adhere  to visceral endoderm (VE), a space is drawn in between to show the routes of PC delivery (green). (C) Paracrine Furin and Pace4 activities have been imaged in epiblast
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Aells  by analyzing eCFP/citrine ratios of the transgenic biosensor CLIP. Sensitized em
s  a quantitative readout of CLIP cleavage in cultured cells.
nly minimally affected the distribution of DPP-GFP, and 60–80%
f extracellular ligand thus was estimated to bind neither TKV
or Punt [154]. So how else is the majority of DPP immobilized?
ikely regulators of this process include the GPI-anchored HSPGs
ally and Dally-like which bind a lysine- and arginine-rich basic
equence at the N-terminus of mature DPP next to the PC recog-
ition motif RNKR [157]. While clones overexpressing Dally show
ncreased endogenous DPP signaling [158,159], lack of Dally and
ly, or failure to sulfate their glycosaminoglycan side chains dra-
atically diminishes the amount of DPP-GFP at the cell surface
nd inhibits DPP signal transduction [160,161]. Mutations in dally
nd dly also inhibit the spreading of DPP activity to wild-type cells
160,161]. It is possible, therefore, that HSPGs inhibit endocytosis
nd facilitate extracellular diffusion of DPP by a capture-and-
elease mechanism. In this model, differences in the concentration
f DPP between producing and receiving cells drive the movement
f DPP from one sulfated side chain to another [157,160]. HSPG
inding sites are found at analogous positions in mature BMP2
nd BMP4 [162,163]. However, endocytosis of recombinant BMP2
ithout its prodomain is facilitated by HSPGs in mammalian cells,
ather than being decreased [164]. Since HSPGs bind close to the
C recognition motif, potential effects of HSPGs on DPP processing
ay  confound their complex inﬂuence on DPP trafﬁcking. In any
ase, since vertebrate HSPGs also bind related ligands such as GDF8,
ctivin A and Nodal [29,165,166] as well as several PCs [104], analysis of Förster resonance energy transfer (FRET) at the indicated wavelengths
they emerge as likely candidates to modulate or spatially localize
the processing of TGF-related precursors in speciﬁc membrane
microdomains.
3.3. TGF  ˇ family members with multiple PC cleavage sites
All known signaling functions of TGF and related factors are
associated with the C-terminal mature domains. Nevertheless,
some precursors of the BMP  subgroup are cleaved at up to three
different PC motifs. In pro-BMP4, multiple PCs can cleave both a dis-
tal site S1 and a proximal site S2, with the exception of PC7 which
only hydrolizes S1 [89,167]. Functional analysis in mice carrying a
mutant knock-in allele established that the S2 site is required for
normal BMP4 function in some tissues, but not in others [168]. This
points to tissue-speciﬁc regulation of ligand turnover because the
BMP4 prodomain remains bound to mature ligand and promotes
its lysosomal degradation when cut only at S1 [169]. Drosophila DPP
even has three PC cleavage sites. In transgenic constructs that were
introduced into dpp-deﬁcient embryos for functional analysis of
long range signaling, only the proximal-most site that corresponds
to S2 of BMP4 was necessary and sufﬁcient for the maturation of
functional DPP and for its release into the extracellular space of
wing imaginal discs [68,170]. In sharp contrast, cleavage of this
proximal site was minimal in embryonic mesoderm and dispens-
able for short range DPP signaling to the gut epithelium [170].
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istinct cleavage sites thus may  be used in a tissue-speciﬁc manner
ccording to the demand for short or long range signaling activ-
ty. Adding to this versatility, the prodomains of the Drosphila BMP
igands Gbb and Scw contain an additional PC cleavage motif, the
o-called Pro site, close to their N-termini [171,172,reviewed in
73]. Cleavage at this position also occurs in Lefty proteins [174],
nd in GDNF (Fig. 2). Superimposed to the structure of L-TGF,  this
osition corresponds to a loop after the same conserved 2 helix
hat is cleaved by Bmp1/Tolloid proteases in GDF8 and GDF11 to
vercome latency [16,50]. Biochemical analysis and genetic rescue
onstructs showed that both the Pro and the Main site have to be
leaved to release Scw from the straighjacket and to unleash its
ctivity. By contrast, cleavage at the Pro site was sufﬁcient to acti-
ate Gbb, and the human Gbb homolog BMP7 did not require any
unctional PC cleavage motif at all to signal [172]. These observa-
ions indicate that different ligands can use PC motifs at distinct
ocations within the prodomain to unmask their receptor bind-
ng epitopes. Moreover, the cleavage-independent activity of BMP7
oncurs with earlier ﬁndings on Nodal processing and corroborates
hat some prodomains of TGF-related precursors do not abol-
sh receptor binding. Proteolytic processing in these instances may
e more important to control interactions with speciﬁc regulatory
actors than to unmask receptor binding sites of mature ligand.
. Emerging concepts and future directions
In sum, precursor processing can be regulated by several differ-
nt mechanisms. An obvious ﬁrst option is to control the expression
evels of individual PCs (Fig. 5A). For example, upregulation of Furin
nd Pace4 expression in the extraembryonic ectoderm of gastrulat-
ng mouse embryos, and local repression in the epiblast lineage are
ikely important to control the activities of Nodal in space and time.
xpression of Furin is under feedback regulation by Nodal in both
ig. 5. Mechanisms that regulate PC activities and the processing of TGF-related precu
A–C)  will affect multiple substrates, alternative cleavage motifs (D) and interactions of su
n  a tissue-speciﬁc manner. (F and G) Sorting determinants in prodomains can be used
onvertases in speciﬁc membrane and tissue compartments. See text for details.pmental Biology 32 (2014) 85–97 93
of these lineages [43,127,175]. One of three Furin promoters also
directly responds to TGF [176], whereas speciﬁc microRNAs such
as miR-24 can mediate negative feedback [177]. Feedback mech-
anisms to regulate Furin and other PCs will also likely emerge in
other contexts. A second layer of regulation of PCs involves their
maturation from inactive zymogens. Even after their autocleav-
age in the ER, inhibitory prodomains of PCs can mask the catalytic
cleft (Fig. 5B). In the case of Furin, a second autocleavage is pH-
dependent since the histidine content of the prodomain acts as a
pH sensor to mediate a conformational change [178]. As this step is
rate-limiting, endogenous Furin may  be inactive until a ﬁrst round
of recycling in acidic endosomes. It will be important to quantify
the fraction of Furin that is re-cycled from endosomes to the TGN at
endogenous expression levels. In cells where shedding is efﬁcient
and endogenous expression levels are low, not much Furin may  be
left to replenish the TGN with active enzyme by means of endo-
somal recycling (Fig. 5C). Furthermore, the ﬁnding that PACE4 and
PCSK5 zymogens are activated at the plasma membrane empha-
sizes the need to investigate how this step is regulated in whole
tissues.
Regulated zymogenic activation and modulation of PC expres-
sion levels will affect multiple substrates simultaneously. To
selectively regulate only a speciﬁc substrate, alternative mecha-
nisms are required. Tissue-speciﬁc use of alternative PC motifs
within the same precursor e.g. of DPP has emerged as a conceptu-
ally novel regulatory mechanism [170] (Fig. 5D). A related, though
poorly understood regulatory determinant involves the actual PC
recognition motif and its ﬂanking sequences. One example might
be GDF11, which was preferentially cleaved by PCSK5 [80]. By con-
trast, BMP10 was mainly cleaved by Furin, at least in vivo. The fact
that these substrates share highly similar cleavage motifs points
to complex inﬂuences of other features. But while speciﬁc ﬂanking
residues may  inﬂuence cleavage rates, they cannot readily explain
rsors. (A–E) While regulation of the distribution and zymogen maturation of PCs
bstrates with dedicated inhibitors (E) can modulate processing of a given precursor
 to regulate co-localization (F) or the segregation (G) of a given substrate and its
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bserved substrate preferences of individual PCs in vivo. The stud-
es on Emilin-1 and ESL-1 show that the conformation or sterical
ccessibility of a given PC cleavage motif can also be regulated by
peciﬁc interacting factors (Fig. 5E). In their physiological contexts
n mice, these factors preferentially inhibit the maturation of TGF.
hey may  be important to control not only the rate, but also the
ocalization of proteolytic processing in speciﬁc subcellular or tis-
ue compartments. Since the interactions of ESL-1 and LTBP with
-TGF  are mutually exclusive [117], they likely inﬂuence when
nd where TGF meets its convertases. It will be important to learn
hether analogous molecules regulate the proteolytic maturation
f TGF or of related PC substrates in other tissues and in human
iseases.
The most versatile, but probably least understood mechanism to
ontrol precursor cleavage is spatial compartmentalization, which
ay  be subdivided into several types (Fig. 5F, G). Passive co-
ocalization may  be compared to two next-door neighbors who
ommute on the same bus line to the same university: The proba-
ility that they meet daily even before arrival at the workplace is
igh. In this scenario, which corresponds to the traditional view
f TGF processing by Furin in the TGN, precursor cleavage is
imited by the duration of the joint “commute”. By contrast, active
o-localization may  be illustrated by co-workers who  choose
ar-pooling as their means of transportation. This pattern likely
orresponds to the behavior of Nodal and Furin, which congre-
ate on the co-receptor Cripto to be at the same place at the right
ime. Depending on whose car they use, they may  or may  not
rrive at work: An unsafe car illustrates the proposed role of Sor-
ilin [142], because it too binds TGF-related precursors as well as
urin, but for lysosomal delivery. Since Sortilin itself must ﬁrst be
leaved before it can load cargo [179], its clearance function may
nly engage when there is too much Furin (Fig. 4A). Temporary
egregation is illustrated by neighbors who commute in separate
ars and thus only communicate in the work place. Such a rela-
ionship appears to exist between Furin and ()proGDNF as they
ravel in distinct exocytic vesicles. If the same neighbors develop
 more antagonistic relationship, one of them might change shifts,
is job or move house to further minimize contact. Though not
et described for any TGF family member, this permanent seg-
egation would describe a hypothetical substrate and a PC that are
ecreted on opposite sides of a polarized epithelium. Alternatively,
ermanent segregation could be achieved by a TGF that represses
xpression of a candidate PC.
Spatial compartmentalization can be implemented and mod-
ﬁed by simply altering intrinsic sorting signals in prodomains
ithout the need for special inhibitors that always bear the risk of
ollateral effects on related ligands. After all, this may  be the reason
or the dramatic diversiﬁcation among TGF-related prodomains,
nd why this form of regulation prevails over still elusive PC-
peciﬁc endogenous inhibitors. However, elucidating this complex
orm of regulation and its function in diverse contexts is a daunting
ask that will likely require new and more sensitive technolo-
ies to track single molecules and to monitor effects of proteolytic
rocessing on protein-protein interactions, trafﬁcking and protein
tability.
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